Personalis, Inc. (PSNL)
NASDAQ: PSNL · Real-Time Price · USD
7.50
-0.10 (-1.32%)
At close: Nov 14, 2025, 4:00 PM EST
7.47
-0.03 (-0.40%)
After-hours: Nov 14, 2025, 7:39 PM EST
Personalis Market Cap
Personalis has a market cap or net worth of $666.92 million as of November 14, 2025. Its market cap has increased by 126.65% in one year.
Market Cap
666.92M
Enterprise Value
558.28M
1-Year Change
126.65%
Ranking
Category
Stock Price
$7.50
Market Cap Chart
Since June 20, 2019, Personalis's market cap has decreased from $847.61M to $666.92M, a decrease of -21.32%. That is a compound annual growth rate of -3.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 14, 2025 | 666.92M | 62.47% |
| Dec 31, 2024 | 410.49M | 298.67% |
| Dec 29, 2023 | 102.97M | 13.12% |
| Dec 30, 2022 | 91.02M | -85.76% |
| Dec 31, 2021 | 639.07M | -55.16% |
| Dec 31, 2020 | 1.43B | 318.66% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 20, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 923.29B |
| Johnson & Johnson | 472.75B |
| AbbVie | 414.35B |
| UnitedHealth Group | 292.13B |
| AstraZeneca | 276.17B |
| Novartis AG | 256.16B |
| Merck & Co. | 234.95B |
| Abbott Laboratories | 226.49B |